SMTL ID : 4qp9.1

Crystal Structure of ERK2 in complex with 7-(1-propyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x 35X: 7-(1-propyl-1H-pyrazol-4-yl)-2-(pyridin-4-yl)-5H-pyrrolo[2,3-b]pyrazine(Non-covalent)

35X.1: 14 residues within 4Å: Chain A: I.40, Y.45, A.61, Q.114, D.115, L.116, M.117, E.118, D.120, K.123, S.162, L.165, C.175, D.176 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.40, A:Y.45, A:L.165 Hydrogen bonds: A:K.63, A:D.115, A:M.117 Water bridges: A:D.176

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Burdick, D.J. et al., Fragment-based discovery of potent ERK2 pyrrolopyrazine inhibitors. Bioorg.Med.Chem.Lett. (2015)

Release Date

2015-09-23

Peptides

Mitogen-activated protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 1

Related Entries With Identical Sequence